BDBM218672 US9289400, PBZI

SMILES CCCN1CCC2C1CCc1ccc(O)cc21

InChI Key InChIKey=LJDRQPOQHHOXHM-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 218672   

TargetSodium-dependent serotonin transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 1.38E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 860nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 1.61E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent